• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测和表征七跨膜受体调节剂的三重添加分析方案。

Triple-addition assay protocols for detecting and characterizing modulators of seven-transmembrane receptors.

作者信息

Weaver C David

机构信息

Vanderbilt University School of Medicine, Nashville, Tennessee.

出版信息

Curr Protoc Chem Biol. 2011 Sep 1;3(3):119-40. doi: 10.1002/9780470559277.ch110060.

DOI:10.1002/9780470559277.ch110060
PMID:23801564
Abstract

The detection and characterization of seven-transmembrane-receptor modulators (orthosteric binding site agonists, antagonists, and more recently allosteric modulators) is an area of intense interest for both drug discovery and basic research. Traditionally, assays used to detect and characterize these different modes of modulation have been executed as separate, discrete protocols focused on a particular mode of action (e.g., agonism). In recent years, investigators have begun to combine aspects of these separate protocols to produce methods that detect multiple modes of modulation simultaneously. The power of such approaches is revealed not only in conservation of time and resources, but more importantly in a superior ability to discover and characterize novel modulators of the targets of interest. The protocols in this article describe a general procedure for developing, validating, and utilizing triple-addition assays to enable the simultaneous detection and characterization of multiple modes of seven-transmembrane-receptor modulation. Curr. Protoc. Chem. Biol. 3:119-140 © 2011 by John Wiley & Sons, Inc.

摘要

七跨膜受体调节剂(正构结合位点激动剂、拮抗剂以及最近的变构调节剂)的检测与特性分析,是药物研发和基础研究都极为关注的领域。传统上,用于检测和表征这些不同调节模式的测定法,都是作为专注于特定作用模式(如激动作用)的独立、离散方案来执行的。近年来,研究人员已开始将这些独立方案的各个方面结合起来,以产生能同时检测多种调节模式的方法。此类方法的优势不仅体现在节省时间和资源上,更重要的是,在发现和表征目标靶点新型调节剂方面具有更强的能力。本文中的方案描述了开发、验证和利用三重添加测定法的一般程序,以实现对七跨膜受体多种调节模式的同时检测和表征。《化学与生物学实验指南》第3卷:119 - 140页 2011年 约翰威立国际出版公司版权所有

相似文献

1
Triple-addition assay protocols for detecting and characterizing modulators of seven-transmembrane receptors.用于检测和表征七跨膜受体调节剂的三重添加分析方案。
Curr Protoc Chem Biol. 2011 Sep 1;3(3):119-40. doi: 10.1002/9780470559277.ch110060.
2
Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.家族 C G 蛋白偶联受体的别构调节:从分子见解到治疗视角。
Pharmacol Rev. 2011 Mar;63(1):59-126. doi: 10.1124/pr.109.002501. Epub 2011 Jan 12.
3
Strategies for the identification of allosteric modulators of G-protein-coupled receptors.G 蛋白偶联受体变构调节剂的鉴定策略。
Biochem Pharmacol. 2011 Mar 15;81(6):691-702. doi: 10.1016/j.bcp.2010.12.012. Epub 2010 Dec 22.
4
Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.变构调节 G 蛋白偶联受体:药理学视角。
Neuropharmacology. 2011 Jan;60(1):24-35. doi: 10.1016/j.neuropharm.2010.07.010. Epub 2010 Jul 15.
5
Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry.通过亲和选择质谱法发现并表征正构和变构毒蕈碱M2型乙酰胆碱受体配体
J Biomol Screen. 2006 Mar;11(2):194-207. doi: 10.1177/1087057105284340. Epub 2006 Feb 20.
6
Allosteric modulation of G-protein coupled receptors.G蛋白偶联受体的变构调节
Eur J Pharm Sci. 2004 Mar;21(4):407-20. doi: 10.1016/j.ejps.2003.11.007.
7
Fluorescence Polarization (FP) Assays for Monitoring Peptide-Protein or Nucleic Acid-Protein Binding.用于监测肽-蛋白质或核酸-蛋白质结合的荧光偏振(FP)分析
Curr Protoc Chem Biol. 2009 Dec 1;1(1):1-15. doi: 10.1002/9780470559277.ch090102.
8
G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms.G蛋白偶联受体:从经典调节模式到变构机制
ACS Chem Biol. 2008 Sep 19;3(9):530-41. doi: 10.1021/cb800116f. Epub 2008 Jul 25.
9
Allosteric modulation of G protein-coupled receptors: perspectives and recent developments.G蛋白偶联受体的变构调节:观点与最新进展
Drug Discov Today. 2004 Sep 1;9(17):752-8. doi: 10.1016/S1359-6446(04)03220-9.
10
Seven transmembrane receptors as nature's prototype allosteric protein: de-emphasizing the geography of binding.作为自然界原型变构蛋白的七跨膜受体:弱化结合的空间定位
Mol Pharmacol. 2008 Sep;74(3):541-3. doi: 10.1124/mol.108.050062. Epub 2008 Jun 26.

引用本文的文献

1
Discovery and characterization of 2-(cyclopropanesulfonamido)-N-(2-ethoxyphenyl)benzamide, ML382: a potent and selective positive allosteric modulator of MrgX1.2-(环丙烷磺酰胺基)-N-(2-乙氧基苯基)苯甲酰胺(ML382)的发现与特性:一种强效且选择性的MrgX1正向变构调节剂
ChemMedChem. 2015 Jan;10(1):57-61. doi: 10.1002/cmdc.201402277. Epub 2014 Sep 10.
2
Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.探测跨膜 7 螺旋受体变构相互作用的方法。
Prog Mol Biol Transl Sci. 2013;115:1-59. doi: 10.1016/B978-0-12-394587-7.00001-4.